Burleson & Company, LLC Abbott Laboratories Call Options Transaction History
Burleson & Company, LLC
- $384 Million
- Q4 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ABT
# of Institutions
3,185Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.9 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9.11 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.81 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.33 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $208B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...